Persistent Renin Suppression After Unilateral Adrenalectomy for Primary Aldosteronism: Implications for Adverse Outcome?
The Journal of Clinical Endocrinology & Metabolism · 22.04.2026 · 111 (5) · e1381-e1387
DOI: 10.1210/clinem/dgaf595 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.11.2025. Verfasst von Isabel Stüfchen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine IV, Endocrinology, Diabetology and Metabolism, LMU University Hospital, LMU Munich, Munich 80336, Germany. Hauptthemen laut MEDLINE: Hyperaldosteronism, Renin, Adrenalectomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Clinician Scientist Program of the Deutsche Forschungsgemeinschaft, CRC/Transregio, The Adrenal: Central Relay in Health and Disease.
Abstract (Originalsprache)
Context
Suppressed renin concentrations in medically treated patients with primary aldosteronism (PA) are associated with a worse cardiometabolic outcome compared to patients with normalized renin levels. No similar study has been conducted in patients with PA after unilateral adrenalectomy.
Objective
This study investigates the prevalence and impact of persistent renin suppression after unilateral adrenalectomy in patients with lateralized PA.
Methods
We retrospectively included 77 patients who underwent adrenalectomy for lateralized PA. All patients had postoperative renin levels available. Patients were divided into tertiles based on their direct renin concentrations (DRC) (<8 mU/L, 8-16 mU/L, >16 mU/L) at the first follow-up, approximately 6 months after surgery. Study endpoints included histopathology using CYP11B2 staining according to HISTALDO consensus, biochemical and clinical outcomes according to the PASO criteria and improvement of comorbidities and end-organ damage at short- and long-term follow-up up to 3 years postoperatively.
Results
Patients with DRC <8 mU/L showed a higher prevalence of non-classical histopathology compared to the other 2 tertiles (8/26 [30.8%] vs 1/25 [4%] vs 3/26 [11.5%]; P = .024) and more frequently absent or partial biochemical remission at their first follow-up (9/26 [34.6%] vs 3/25 [12.0%] vs 2/26 [7.7%]; P = .036). Nonetheless, 65.4% achieved complete biochemical remission. Clinical outcomes, including end-organ damage and comorbidities, did not differ across the tertiles.
Conclusion
Persistent renin suppression is common 6 months after adrenalectomy and associated with worse biochemical but not clinical outcomes. More than 60% of patients with DRC <8 mU/L achieved full biochemical remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine IV, Endocrinology, Diabetology and Metabolism, LMU University Hospital, LMU Munich, Munich 80336, Germany.
- Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich 80336, Germany.
ORCID-Profile: Isabel Stüfchen, Martin Bidlingmaier, Martin Reincke
Förderung
- Clinician Scientist Program of the Deutsche Forschungsgemeinschaft
- CRC/Transregio
- The Adrenal: Central Relay in Health and Disease
- Else Kröner-Fresenius Stiftung
- German Conn's Registry-Else-Kröner Hyperaldosteronism Registry
- European Research Council under the European Union Horizon 2020
- Deutsche Forschungsgemeinschaft (DFG)
- German Conn’s Registry-Else-Kröner Hyperaldosteronism Registry
Zitieren
APA
Stüfchen, I., Williams, T. A., Schweizer, J. R. O. L., Völter, F., Zopp, S., Petersenn, E., Bidlingmaier, M., Brüdgam, D., Kroiss, M., Oettle, M., Schrenk, M., Zimmermann, P., & Reincke, M. (2026). Persistent Renin Suppression After Unilateral Adrenalectomy for Primary Aldosteronism: Implications for Adverse Outcome?. The Journal of Clinical Endocrinology & Metabolism, 111(5), e1381-e1387. https://doi.org/10.1210/clinem/dgaf595
Vancouver
Stüfchen I, Williams TA, Schweizer JROL, Völter F, Zopp S, Petersenn E, et al. Persistent Renin Suppression After Unilateral Adrenalectomy for Primary Aldosteronism: Implications for Adverse Outcome?. The Journal of Clinical Endocrinology & Metabolism. 2026;111(5):e1381-e1387. doi:10.1210/clinem/dgaf595
BibTeX
@article{Stfchen2026,
author = {Stüfchen, Isabel and Williams, Tracy Ann and Schweizer, Júnia R O L and Völter, Friederike and Zopp, Stephanie and Petersenn, Erik and Bidlingmaier, Martin and Brüdgam, Denise and Kroiss, Markus and Oettle, Matthias and Schrenk, Moritz and Zimmermann, Petra and Reincke, Martin},
title = {Persistent Renin Suppression After Unilateral Adrenalectomy for Primary Aldosteronism: Implications for Adverse Outcome?},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {5},
pages = {e1381--e1387},
doi = {10.1210/clinem/dgaf595}
}
EUVIMED